NEO compared with TECX: revenue, margins and what each company keeps, and the suppliers and customers both name

NEONeogenomics Inc

Mkt capRevenueRevenue

TECXTectonic Therapeutic, Inc.

Mkt capRevenueRevenue

Compare

NEONeogenomics Inc

TECXTectonic Therapeutic, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NEO: latest quarter is a loss; flow not drawable. TECX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: NEO, TECX.

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

NEO, solidTECX, dashed

NEONeogenomics Inc

17.38▼−3.07%· post 17.38

Mkt cap$2.2BRevenue$209MQ3 FY26Revenue$727MFY25

TECXTectonic Therapeutic, Inc.

19.65▼−4.17%· post 19.65

ClosedOct 30 '26

Mkt cap$386.7MRevenue—Revenue—

Compare

ClosedOct 30 '26

NEONeogenomics Inc

TECXTectonic Therapeutic, Inc.

17.38▼−3.07%post 17.38

Price

19.65▼−4.17%post 19.65

$2.2B

Mkt cap

$386.7M

Q3 FY26$209M

Revenue

—

FY25$727M

Revenue

—

NEO17.38▼−3.07%vsTECX19.65▼−4.17%ClosedOct 30 '26